Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 162
Selected: 0
NCT IDTitle
NCT06425796Adiposity and Iron Requirements in Pregnancy
NCT03180957Repurposing Anti-TNF for Treating Dupuytren's Disease
NCT04708782Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
NCT05421897Rapid Administration Pilot for Infusing Dinutuximab
NCT01884038Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients
NCT00004497Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
NCT04050449Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD
NCT04287478Bacteriophage Therapy in Patients With Urinary Tract Infections
NCT01104870A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension
NCT00147199Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)
NCT02370095Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
NCT01273922Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida
NCT04341948Treatment of Post-Operative Pain Following Orthopedic Surgery With SPRINT® Peripheral Nerve Stimulation (PNS) System
NCT07261241NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab
NCT02318186Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)
NCT01593072A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
NCT05245006PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer
NCT05340426Porcine Kidney Xenotransplantation in Patients With End-Stage Kidney Disease
NCT05203510A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension
NCT01795950Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)
NCT03833323Implantable System for Remodulin Post-Approval Study
NCT04707664Sargramostim Use in COVID-19 to Recover Patient Health
NCT02882126An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension
NCT04478071Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
NCT02276872Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years
NCT05564637A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
NCT01027949An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension
NCT01043627Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
NCT04868292Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers
NCT01028651A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
NCT01131845The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil
NCT01447407Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine
NCT00775463Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine
NCT06388421DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT01477333Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
NCT00760916FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
NCT00692354Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours
NCT02693171Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients
NCT03012646Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
NCT01153386Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine
NCT02633293An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
NCT02318758Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers
NCT06335407Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
NCT06477640Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension
NCT01353040Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
NCT00373360Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin
NCT03367312Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
NCT04827056Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
NCT03047369The Myelin Disorders Biorepository Project
NCT00887978Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension